Microcarriers Market to Hit USD 3.05 Billion by 2029 with 8.0% CAGR | MarketsandMarkets
The global Microcarriers market, valued at US$2.03 billion in 2023, is forecasted to grow at a robust CAGR of 8.0%, reaching US$2.08 billion ...
Le Lézard1d
Microcarriers Market to Hit USD 3.05 Billion by 2029 with 8.0% CAGR | MarketsandMarketstm
The global Microcarriers market, valued at US$2.03 billion in 2023, is forecasted to grow at a robust CAGR of 8.0%, reaching US$2.08 billion in 2024 and an impressive US$3.05 billion by 2029. Market ...
Validated Claim Support, Now Accredited by the BBB, Enhances Consumer Confidence with Cutting-edge Clinical Testing Services
VCS’s innovative and custom-tailored testing services offer specialized cosmetic clinical testing while helping to provide ...
Molecular Infectious Disease Testing Market to Hit USD 17.78 Billion by 2029 with 13.7% CAGR | MarketsandMarkets™.
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust ...
Companion Diagnostics Market Trends 2019-2024 and Forecast to 2034 - Rising Number of Targeted Therapies Driving the $8.75 Billion Industry
Companion Diagnostics Market Companion Diagnostics Market Dublin, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The "Companion ...
Cell Therapy Human Raw Materials Market Research Report 2025-2030: Revenues Set to Double, Reaching $5.43 Billion by 2030
Presents Analysis of Industry Giants, Including Thermo Fisher Scientific, Merck, Danaher Corporation, Sartorius, and Aceto ...
pharmaphorum2d
On Clinical Trials Day, CVS shares lessons learned from one year providing trial services
the company added clinical trials to the list with the launch of CVS Health Clinical Trial Services, an initiative that works with pharma companies on clinical trial recruitment and even hosts ...
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
Respiratory Diagnostics Market to Hit USD 9.02 Billion by 2030 with 6.5% CAGR | MarketsandMarkets™
The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5% ...
Le Lézard3d
A2P SMS Market Size Worth $91.59 Billion, Globally, by 2031 Growing at 3.4% CAGR | Exclusive Report by The Insight Partners
The global A2P SMS market is set for explosive growth with a CAGR of 3.4% during 2025?2031, it was valued at $72.48 billion in 2024 and with projections indicating a surge to $91.59 billion by 2031.